Group One Trading, L.P. Orchard Therapeutics PLC Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.7 - $1.51 $36,582 - $78,914	-52,261 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$1.16 - $2.23 $37,818 - $72,702	-32,602 Reduced 38.42%	52,261 $69,000
Q3 2021 Nov 12, 2021	BUY	$2.24 - $4.29 $76,679 - $146,855	34,232 Added 67.61%	84,863 $195,000
Q2 2021 Aug 10, 2021	SELL	$4.39 - $7.23 $51,086 - $84,135	-11,637 Reduced 18.69%	50,631 $222,000
Q1 2021 May 12, 2021	SELL	$4.39 - $9.08 $141,147 - $291,940	-32,152 Reduced 34.05%	62,268 $452,000
Q4 2020 Feb 10, 2021	BUY	$3.86 - $5.07 $354,224 - $465,263	91,768 Added 3460.33%	94,420 $408,000
Q3 2020 Nov 12, 2020	BUY	$4.11 - $6.45 $10,899 - $17,105	2,652 New	2,652 $11,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.